Osteoporosis and fractures in postmenopausal women using estrogen.

PubWeight™: 0.78‹?›

🔗 View Article (PMID 12418942)

Published in Arch Intern Med on November 11, 2002

Authors

Heidi D Nelson1, Joanne Rizzo, Emily Harris, Jane Cauley, Kristine Ensrud, Douglas C Bauer, Eric Orwoll, Study of Osteoporotic Fractures Research Group

Author Affiliations

1: Department of Medical Informatics and Outcomes Research, Oregon Health and Science University, Mailcode BICC-504, 3181 SW Sam Jackson Park Rd, Portland, OR 97201, USA. nelsonh@ohsu.edu

Articles by these authors

Gait speed and survival in older adults. JAMA (2011) 15.01

Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial. JAMA (2006) 12.47

Design and baseline characteristics of the osteoporotic fractures in men (MrOS) study--a large observational study of the determinants of fracture in older men. Contemp Clin Trials (2005) 9.57

Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res (2007) 6.76

Prognostic value of usual gait speed in well-functioning older people--results from the Health, Aging and Body Composition Study. J Am Geriatr Soc (2005) 6.54

Bisphosphonates and fractures of the subtrochanteric or diaphyseal femur. N Engl J Med (2010) 6.47

Bone-density testing interval and transition to osteoporosis in older women. N Engl J Med (2012) 5.81

Lasofoxifene in postmenopausal women with osteoporosis. N Engl J Med (2010) 5.60

Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA (2010) 5.20

High-trauma fractures and low bone mineral density in older women and men. JAMA (2007) 5.00

BMD at multiple sites and risk of fracture of multiple types: long-term results from the Study of Osteoporotic Fractures. J Bone Miner Res (2003) 4.64

Daily activity energy expenditure and mortality among older adults. JAMA (2006) 4.36

Therapy modifications in response to poorly controlled hypertension, dyslipidemia, and diabetes mellitus. Ann Intern Med (2006) 3.71

Subclinical hypothyroidism and the risk of heart failure, other cardiovascular events, and death. Arch Intern Med (2005) 3.56

Fracture risk and zoledronic acid therapy in men with osteoporosis. N Engl J Med (2012) 3.51

Nontraumatic fracture risk with diabetes mellitus and impaired fasting glucose in older white and black adults: the health, aging, and body composition study. Arch Intern Med (2005) 3.39

A comparison of prediction models for fractures in older women: is more better? Arch Intern Med (2009) 3.37

Circulating levels of inflammatory markers and cancer risk in the health aging and body composition cohort. Cancer Epidemiol Biomarkers Prev (2005) 3.20

Meta-analysis: subclinical thyroid dysfunction and the risk for coronary heart disease and mortality. Ann Intern Med (2008) 3.20

Frailty and risk of falls, fracture, and mortality in older women: the study of osteoporotic fractures. J Gerontol A Biol Sci Med Sci (2007) 3.16

Noncardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). JAMA (2002) 3.13

Improvement in spine bone density and reduction in risk of vertebral fractures during treatment with antiresorptive drugs. Am J Med (2002) 3.10

Central nervous system-active medications and risk for falls in older women. J Am Geriatr Soc (2002) 3.03

Parathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its use. Endocr Rev (2005) 3.01

Incidence and demography of femur fractures with and without atypical features. J Bone Miner Res (2012) 2.85

A drug burden index to define the functional burden of medications in older people. Arch Intern Med (2007) 2.84

Factors associated with 5-year risk of hip fracture in postmenopausal women. JAMA (2007) 2.81

Testosterone and estradiol among older men. J Clin Endocrinol Metab (2005) 2.63

Cost-effectiveness of bone densitometry followed by treatment of osteoporosis in older men. JAMA (2007) 2.62

Inflammatory markers and incident heart failure risk in older adults: the Health ABC (Health, Aging, and Body Composition) study. J Am Coll Cardiol (2010) 2.43

Relationship of changes in physical activity and mortality among older women. JAMA (2003) 2.42

Hip fracture in women without osteoporosis. J Clin Endocrinol Metab (2005) 2.35

Incident heart failure prediction in the elderly: the health ABC heart failure score. Circ Heart Fail (2008) 2.33

Electronic medical record reminder improves osteoporosis management after a fracture: a randomized, controlled trial. J Am Geriatr Soc (2006) 2.33

Central nervous system active medications and risk for fractures in older women. Arch Intern Med (2003) 2.30

Efficacy of continued alendronate for fractures in women with and without prevalent vertebral fracture: the FLEX trial. J Bone Miner Res (2010) 2.29

Proton pump inhibitors and risk of fractures: a meta-analysis of 11 international studies. Am J Med (2011) 2.27

Subclinical hyperthyroidism and the risk of coronary heart disease and mortality. Arch Intern Med (2012) 2.24

The incidence of osteonecrosis of the jaw in patients receiving 5 milligrams of zoledronic acid: data from the health outcomes and reduced incidence with zoledronic acid once yearly clinical trials program. J Am Dent Assoc (2010) 2.19

Association of low bone mineral density with selective serotonin reuptake inhibitor use by older men. Arch Intern Med (2007) 2.17

Diabetes and incidence of functional disability in older women. Diabetes Care (2002) 2.16

Risk for fracture in women with low serum levels of thyroid-stimulating hormone. Ann Intern Med (2001) 2.13

The Human Microbiome Project strategy for comprehensive sampling of the human microbiome and why it matters. FASEB J (2012) 2.13

The burden of urinary incontinence and urinary bother among elderly prostate cancer survivors. Eur Urol (2013) 2.10

Association of major and minor ECG abnormalities with coronary heart disease events. JAMA (2012) 2.07

Association of BMD and FRAX score with risk of fracture in older adults with type 2 diabetes. JAMA (2011) 2.04

Value of routine monitoring of bone mineral density after starting bisphosphonate treatment: secondary analysis of trial data. BMJ (2009) 2.00

Relationship of changes in total hip bone mineral density to vertebral and nonvertebral fracture risk in women with postmenopausal osteoporosis treated with once-yearly zoledronic acid 5 mg: the HORIZON-Pivotal Fracture Trial (PFT). J Bone Miner Res (2012) 1.98

Oral bisphosphonates and upper gastrointestinal tract problems: what is the evidence? Mayo Clin Proc (2002) 1.97

Randomized trial of effect of alendronate continuation versus discontinuation in women with low BMD: results from the Fracture Intervention Trial long-term extension. J Bone Miner Res (2004) 1.93

Circulating 25-hydroxyvitamin D levels and frailty status in older women. J Clin Endocrinol Metab (2010) 1.93

Predictors of non-spine fracture in elderly men: the MrOS study. J Bone Miner Res (2007) 1.93

Association of kidney function with incident hip fracture in older adults. J Am Soc Nephrol (2006) 1.92

Racial variation in the relationship of anemia with mortality and mobility disability among older adults. Blood (2007) 1.92

Relationship between bone mineral density changes with denosumab treatment and risk reduction for vertebral and nonvertebral fractures. J Bone Miner Res (2012) 1.92

Free testosterone is an independent predictor of BMD and prevalent fractures in elderly men: MrOS Sweden. J Bone Miner Res (2006) 1.91

Subclinical hypothyroidism and functional mobility in older adults. Arch Intern Med (2009) 1.91

The association between sleep duration and obesity in older adults. Int J Obes (Lond) (2008) 1.89

Alendronate treatment in women with normal to severely impaired renal function: an analysis of the fracture intervention trial. J Bone Miner Res (2007) 1.88

Vision impairment and combined vision and hearing impairment predict cognitive and functional decline in older women. J Am Geriatr Soc (2004) 1.88

Hip bone density predicts breast cancer risk independently of Gail score: results from the Women's Health Initiative. Cancer (2008) 1.84

Factors associated with kyphosis progression in older women: 15 years' experience in the study of osteoporotic fractures. J Bone Miner Res (2013) 1.84

Factors associated with the lumbar spine and proximal femur bone mineral density in older men. Osteoporos Int (2005) 1.82

Obesity increases and physical activity decreases lower urinary tract symptom risk in older men: the Osteoporotic Fractures in Men study. Eur Urol (2011) 1.81

Statin use, clinical fracture, and bone density in postmenopausal women: results from the Women's Health Initiative Observational Study. Ann Intern Med (2003) 1.81

High serum testosterone is associated with reduced risk of cardiovascular events in elderly men. The MrOS (Osteoporotic Fractures in Men) study in Sweden. J Am Coll Cardiol (2011) 1.81

Bisphosphonate therapy for osteoporosis: benefits, risks, and drug holiday. Am J Med (2012) 1.80

Osteoporosis in men. Endocr Rev (2008) 1.80

Subclinical thyroid dysfunction and the risk of heart failure events: an individual participant data analysis from 6 prospective cohorts. Circulation (2012) 1.79

Continuing bisphosphonate treatment for osteoporosis--for whom and for how long? N Engl J Med (2012) 1.79

Preparedness of the CTSA's structural and scientific assets to support the mission of the National Center for Advancing Translational Sciences (NCATS). Clin Transl Sci (2012) 1.76

Low serum testosterone and high serum estradiol associate with lower extremity peripheral arterial disease in elderly men. The MrOS Study in Sweden. J Am Coll Cardiol (2007) 1.75

Prevalence, severity, and health correlates of lower urinary tract symptoms among older men: the MrOS study. Urology (2006) 1.75

Comparison of sleep parameters from actigraphy and polysomnography in older women: the SOF study. Sleep (2008) 1.75

Long-term cognitive and functional effects of potentially inappropriate medications in older women. J Gerontol A Biol Sci Med Sci (2013) 1.74

Finite element analysis of the proximal femur and hip fracture risk in older men. J Bone Miner Res (2009) 1.73

Associations between body composition, anthropometry, and mortality in women aged 65 years and older. Am J Public Health (2007) 1.72

Endogenous testosterone levels, physical performance, and fall risk in older men. Arch Intern Med (2006) 1.72

Intentional and unintentional weight loss increase bone loss and hip fracture risk in older women. J Am Geriatr Soc (2003) 1.72

Reference ranges for testosterone in men generated using liquid chromatography tandem mass spectrometry in a community-based sample of healthy nonobese young men in the Framingham Heart Study and applied to three geographically distinct cohorts. J Clin Endocrinol Metab (2011) 1.71

Acid-suppressive medications and risk of bone loss and fracture in older adults. Calcif Tissue Int (2008) 1.71

Epidemiology of incident heart failure in a contemporary elderly cohort: the health, aging, and body composition study. Arch Intern Med (2009) 1.71

The relationship between bisphosphonate adherence and fracture: is it the behavior or the medication? Results from the placebo arm of the fracture intervention trial. J Bone Miner Res (2011) 1.70

Statin use and breast cancer: prospective results from the Women's Health Initiative. J Natl Cancer Inst (2006) 1.70

Quantitative ultrasound in the management of osteoporosis: the 2007 ISCD Official Positions. J Clin Densitom (2008) 1.66

Metabolic syndrome and the risk of cardiovascular disease in older adults. J Am Coll Cardiol (2006) 1.66

Hip fracture and increased short-term but not long-term mortality in healthy older women. Arch Intern Med (2011) 1.64

Number and dosage of central nervous system medications on recurrent falls in community elders: the Health, Aging and Body Composition study. J Gerontol A Biol Sci Med Sci (2009) 1.64

Diabetes is associated independently of body composition with BMD and bone volume in older white and black men and women: The Health, Aging, and Body Composition Study. J Bone Miner Res (2004) 1.64

Cortical pQCT measures are associated with fractures in dialysis patients. J Bone Miner Res (2006) 1.63